Semaglutide Injection: Incorrect Pen in PackageHealth ProductsAug 11th, 2026 @ 12:00 PM
Basic Details
Category: Health products - Drugs
Product: Semaglutide Injection
Issue: Health products - Packaging
What to do: Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot Number |
|---|---|---|---|---|---|
| Dr. Reddy's Laboratories Canada Inc. | Semaglutide Injection (labelled as 2mg/pen) | DIN 02567806 | Solution | 1.34 mg/ml | 7000544C |
Recall Monitor
Information presented from Recalls and Safety Alerts dataset, provided by the Government of Canada through the Open Government initiative and is subject to the Open Government License.
You can access this data free of charge via Recall Monitor, or through the Healthy Canadians website.
Get personalized SMS or Email notifications about recall alerts that matter by subscribing to Recall Monitor.
Recall Monitor is not endorsed by, or is an official product of the Government of Canada.
Made with in Vancouver, BC
© Mad Filaments Software Inc.